Cargando…
Construction and validation of a novel signature based on epithelial-mesenchymal transition–related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment
Immunotherapy has yielded encouraging results in the treatment of advanced hepatocellular carcinoma (HCC). However, the relationship between epithelial-mesenchymal transition (EMT) and immunotherapy for HCC has not been adequately explained. In this study, we comprehensively analyzed a bulk RNA sequ...
Autores principales: | Gao, Biao, Wang, Yafei, Lu, Shichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763151/ https://www.ncbi.nlm.nih.gov/pubmed/36536232 http://dx.doi.org/10.1007/s10142-022-00933-w |
Ejemplares similares
-
Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022) -
Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021) -
Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022) -
Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022) -
Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma
por: Gao, Biao, et al.
Publicado: (2023)